Agios Pharma(DE:8AP)
€27.00-1.20 (-4.26%)
DE:8AP
Agios Pharma earnings date
€27.00
At close:-1.20 (-4.26%)
Agios Pharma (8AP) Q1 2026 Earnings Report
0 Followers
DE:8AP Q1 2026 EPS Results
- Actual EPS
- -EUR 1.53
- Consensus EPS
- -EUR 1.64
- Beat/Miss
- Beat by +EUR 0.10
- One Year Ago EPS
- -EUR 1.41
DE:8AP Q1 2026 Revenue Results
- Actual Revenue
- EUR 18.82M
- Expected Revenue
- EUR 12.07M
- Beat/Miss
- Beat by +EUR 6.75M
- YoY Revenue Growth
- +137.75%
Earnings Announcement Details
- Quarter
- Q1 2026
- Date
- 04/29/2026
- Time
- Before Open
- Conference Call
- Wednesday, April 29, 2026
DE:8AP Upcoming Earnings
Agios Pharma's next earnings date is estimated for February 25, 2027, based on past reporting schedules.
Q1 2026 Earnings Call Audio
DE:8AP Q1 2026 Earnings Call
0:00 / 0:00
Q1 2026 Earnings Slide Deck
Q1 2026 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:8AP Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 25, 2027 | 2026 (Q4) | -1.00- | -1.69 | ― | ― |
| Nov 05, 2026 | 2026 (Q3) | -1.13-0.99 | -1.61 | 38.76% (+0.63) | |
| Jul 30, 2026 | 2026 (Q2) | -1.50-1.53 | -1.75 | 12.44% (+0.22) | |
| Apr 29, 2026 | 2026 (Q1) | -1.64-1.53 | -1.41 | -9.03% (-0.13) | |
| Feb 12, 2026 | 2025 (Q4) | -1.77-1.69 | -1.31 | -29.17% (-0.38) | |
| Oct 30, 2025 | 2025 (Q3) | -1.72-1.61 | 14.71 | -110.97% (-16.33) | |
| Jul 31, 2025 | 2025 (Q2) | -1.64-1.75 | -1.53 | -14.20% (-0.22) | |
| May 01, 2025 | 2025 (Q1) | -1.61-1.41 | -1.32 | -6.90% (-0.09) | |
| Feb 13, 2025 | 2024 (Q4) | -1.53-1.31 | -1.55 | 15.79% (+0.24) | |
| Oct 31, 2024 | 2024 (Q3) | 13.8014.71 | -1.49 | 1089.02% (+16.20) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed


